Annual CAPEX
N/A
31 December 2023
Summary:
Y-mAbs Therapeutics annual capital expenditures is not available.YMAB CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
30 September 2024
Summary:
Y-mAbs Therapeutics quarterly capital expenditures is not available.YMAB Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
30 September 2024
Summary:
Y-mAbs Therapeutics TTM capital expenditures is not available.YMAB TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YMAB CAPEX Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
YMAB CAPEX High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | ||||||
5 y | 5 years | ||||||
alltime | all time |
Y-mAbs Therapeutics CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | $967.00 K | $455.00 K(+540.8%) | $967.00 K(+73.9%) |
Sept 2021 | - | $71.00 K(+73.2%) | $556.00 K(+14.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2021 | - | $41.00 K(-89.8%) | $485.00 K(+9.2%) |
Mar 2021 | - | $400.00 K(+809.1%) | $444.00 K(+909.1%) |
Dec 2020 | $175.00 K | $44.00 K | $44.00 K |
FAQ
- What is the all time high annual CAPEX for Y-mAbs Therapeutics?
- What is the all time high quarterly CAPEX for Y-mAbs Therapeutics?
- What is the all time high TTM CAPEX for Y-mAbs Therapeutics?
What is the all time high annual CAPEX for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual capital expenditures is $967.00 K
What is the all time high quarterly CAPEX for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly capital expenditures is $455.00 K
What is the all time high TTM CAPEX for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high TTM capital expenditures is $967.00 K